Patent ID: 6303630
Filing Date: 2001-10-16
Classification: A61P,C07C,C07D

Abstract:
A method of treating human immunodeficiency virus infection which comprises administering to a human in need thereof an effective amount of a compound of the formula selected from the group consisting of ##STR32##wherein R.sub.11 is hydrogen, C.sub.1 -C.sub.4 amine, with the proviso that when R.sub.11 is H, R.sub.13 is C.sub.1 -C.sub.4 amine; R.sub.12 is hydrogen, C.sub.1 -C.sub.4 alkyl or halogen; R.sub.13 is hydrogen, C.sub.1 -C.sub.4 amine, with the proviso that when R.sub.13 is H, R.sub.11 is C.sub.1 -C.sub.4 amine; R.sub.14 is hydrogen or halogen; R.sub.15 is nitro; R.sub.16 is hydrogen or nitro; R.sub.17 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro or halogen; R.sub.18 is hydrogen, C.sub.1 -C.sub.4 alkoxy, hydroxy, or halogen; R.sub.19 is nitro; R.sub.20 is hydrogen or halogen; and R.sub.21 is NO.sub.2 ; and pharmaceutically acceptable salts thereof.